BiotechTube
VeinSound

VeinSound

Paris, France· Est.
veinsound.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

VeinSound is a Paris-based, private medical device innovator targeting the large and growing market for varicose vein treatments. Its core technology is a non-thermal HIFU system that uses AI for vein identification and safety, promising a procedure that is fast, painless, and requires no capital expenditure for clinics through a leasing model. The company is currently in the clinical investigation stage, has not commercialized its product, and is collaborating with the French academic research lab LabTAU INSERM. Key near-term milestones will involve completing clinical studies and securing regulatory approvals in major markets like the EU and US.

Venous DiseasesVaricose Veins

Technology Platform

Non-thermal High-Intensity Focused Ultrasound (HIFU) using cavitation, integrated with AI and computer vision for vein identification and safety.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The global varicose vein treatment market is large (>€10B) and growing, driven by demographic trends and demand for minimally invasive options.
VeinSound's unique non-invasive, non-thermal approach could capture significant market share by appealing to needle-averse patients and clinics seeking efficient, in-office procedures with a low-cost leasing model.

Risk Factors

The primary risks are clinical/regulatory, as the novel technology must prove safe and effective in trials and navigate uncertain approval pathways.
The company is pre-revenue and faces significant competition from established medical device giants with proven thermal ablation systems, creating commercialization and adoption challenges.

Competitive Landscape

VeinSound competes in the venous ablation market against large incumbents like Medtronic (VenaSeal glue, radiofrequency), Boston Scientific, and Biolitec (laser), which offer minimally invasive but percutaneous and often thermal-based solutions. Its key differentiation is being the only proposed entirely non-invasive (extracorporeal) and non-thermal option, targeting a niche for ultimate patient comfort and procedural simplicity.

More companies in AI / Machine Learning →More companies in France →